Florian Clatot

7PUBLICATIONS
46CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Cancer diagnosisGene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jan 22, 2026
Induction Nivolumab Before Chemoradiation in High-Risk Human Papillomavirus-Driven Oropharynx Cancers: IMMUNEBOOST-HPV, a Multicenter Randomized Phase II Trial.

Haitham Mirghani, Anne Aupérin, Caroline Even

|Apr 22, 2025
Impact of pembrolizumab on ovarian function in young triple-negative breast cancer patients treated with chemo-immunotherapy.

Anne Perdrix, Nathalie Olympios, Jean Rouvet

|Dec 26, 2023
Treatment Response, Tumor Infiltrating Lymphocytes and Clinical Outcomes in Inflammatory Breast Cancer-Treated with Neoadjuvant Systemic Therapy.

Maxim De Schepper, Ha-Linh Nguyen, François Richard

|Feb 23, 2022
Impact of preoperative staging with contrast-enhanced mammography for localized breast cancer management.

Fanny Montrognon, Florian Clatot, Anca Berghian

|Apr 23, 2021
Association of Germline BRCA Pathogenic Variants With Diminished Ovarian Reserve: A Meta-Analysis of Individual Patient-Level Data.

Volkan Turan, Matteo Lambertini, Dong-Yun Lee

|May 30, 2020
Risk of early progression according to circulating ESR1 mutation, CA-15.3 and cfDNA increases under first-line anti-aromatase treatment in metastatic breast cancer.

Florian Clatot, Anne Perdrix, Ludivine Beaussire

Pageof 2

Frequent Collaborators

2 joint publications

Matteo Lambertini

1 joint publications

Dong-Yun Lee

1 joint publications

Beth Y Karlan

1 joint publications

Isabelle Demeestere